Acuite Ratings and Research logo
 
 
 
 
 
Product Quantum (Rs. Cr) (SEBI) Quantum (Rs. Cr) (Other FSR) Long Term Rating Short Term Rating Regulated By
Bank Loan Ratings 0.00 32.50 ACUITE BBB- | Stable | Reaffirmed - RBI
Bank Loan Ratings 0.00 60.00 - ACUITE A3 | Reaffirmed RBI
Total Outstanding 0.00 92.50 - - -
Total Withdrawn 0.00 0.00 - - -
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
 
Rating Rationale

­­Acuite has reaffirmed its long-term rating of ‘ACUITE BBB-' (read as ACUITE Triple B minus) and short-term rating of ‘ACUITE A3' (read as ACUITE A three) on the Rs. 92.50 Cr. bank facilities of Amjey Chem Trade Private Limited (ACTPL). The outlook is ‘Stable’.

Rationale for Rating Reaffirmation
The rating reaffirmation factors in the sustenance of company's profitability margins despite moderation in revenues. The rating also derives comfort from the company's experienced management and established operational track record along with moderate financial risk profile, marked by a modest net worth base, low gearing  and moderate debt protection metrics, along with an adequate liquidity position. However, the rating remains constrained by the moderately intensive working capital operations and susceptibility of profitability to fluctuations in traded chemical prices and foreign exchange movements in an intensely competitive and fragmented chemical industry.


About the Company
­Incorporated in 2007, Amjey Chem Trade Private Limited (ACTPL) is based in Mumbai, Maharashtra. The company is engaged in trading of wide range of chemicals, over 100 products, used across various industries including plywood, pharmaceuticals, textiles, paints, refineries, dyes, fertilizers, power plants, etc. ACTPL is promoted by Mr. Amit Rajendra Jhawar, Mr. Ashok Kumar Rameshwar Lal Jhanwar and Mr. Sumit Rajendra Prasad Jhanwar. The company’s branches located at Mumbai, Ahmedabad, Delhi, Hyderabad, Vishakhapatnam, and Gurgaon Haryana.
 
Unsupported Rating

­Not Applicable

 
Analytical Approach

­­Acuite has considered the standalone business and financial risk profile of Amjey Chem Trade Private Limited (ACTPL).

 
Key Rating Drivers

Strengths

Experienced Management with Established Track Record of Operations
ACTPL's business profile is supported by the extensive experience of its promoters and company’s established operational track record. The promotes have been associated with the chemical industry for nearly two decades. The company's established operational track record has enabled it to develop long-standing relationships with a diversified customer base comprising reputed entities across the refinery, pharmaceutical, fertilizer, and paint industries, while also maintaining stable associations with key suppliers. These relationships have contributed to business continuity and support operational stability. Acuite believes that the company will continue to benefit from its experienced management and able to sustain established relations with its customers and suppliers over the medium term.


Sustained improvement in overall profitability margins albeit moderation in revenues 
ACTPL's operating performance witnessed moderation over FY2024-FY2026, with operating income declining to Rs. 437.19 crore in FY2026 (Prov.) as compared to Rs. 505.42 crore in FY2025, from Rs. 492.07 Cr. in FY2024. The decline in FY2026 (Prov.) was primarily attributable to geopolitical uncertainties and resultant market volatility, which adversely impacted demand, leading to lower sales volumes and subdued realizations. Despite the moderation in turnover, the company maintained stable operating profitability, with EBITDA margins improving marginally to 1.43 per cent in FY2026 (Prov.) from 1.32 per cent in FY2025, supported by stable operating efficiencies and better absorption of fixed costs.  Further, PAT improved to Rs. 2.04 crore in FY2026 (Prov.) from Rs. 1.38 crore in FY2025, supported by lower finance costs and improved operating efficiencies. Consequently, the PAT margin remained thin however improved and stood at 0.47 percent in FY2026 (Prov.) as against 0.27 percent in FY2025. Notwithstanding the subdued performance in FY2026 (Prov.), the company has reported a strong recovery in scale during H1FY2027, with sales increasing significantly to Rs. 410.26 crore as against Rs. 221.16 crore during the H1FY2026, reflecting improved market conditions, higher trading volumes, and better demand from end user industries. The company reported an EBITDA margin of 1.54 percent during H1FY2027.
Acuite believes that the company's ability to sustain the improved business momentum while maintaining profitability amid volatility in crude oil prices and geopolitical developments will remain a key rating sensitivity over the medium term.


Moderate Financial Risk Profile
The financial risk profile of the company is moderate marked by modest net worth, below unity gearing and comfortable debt protection metrics. The company’s net worth stood at Rs. 58.15 Cr. as on March 31, 2026 (Prov.), from Rs. 56.11 Cr. as on March 31, 2025, due to accretion of profit to reserves. The total debt of the company stood at Rs. 33.18 Cr. as on March 31, 2026 (Prov.), as against Rs. 15.12 Cr. as on March 31, 2025. The debt profile of the company comprises of Rs. 14.69 Cr. of short-term debt and Rs. 18.49 Cr. of unsecured loans from related parties as on March 31, 2026(Prov.). The gearing (Debt- Equity) of the company’s stood at 0.57 times in 2026 (Prov.), as against 0.27 times in FY2025. The Total Outside Liabilities to Tangible Net Worth (TOL/TNW) deteriorated marginally to 2.33 times as on March 31, 2026 (Prov.), from 1.75 times as on March 31, 2025. Further, the Debt/EBITDA ratio deteriorated and stood high at 4.95 times in 2026 (Prov.) from 1.93 times in FY25, reflecting the increase in debt levels to meet working capital requirements. The debt protection metrics remained comfortable as reflected with an interest service coverage ratio (ICR) of 2.42 times as on March 31, 2026 (Prov.), as against 1.84 times as on March 31, 2025. Also, debt service coverage ratio (DSCR) stood at 1.94 times as on March 31, 2026 (Prov.), as against 1.56 times as on March 31, 2025. Acuite believes that the financial risk profile of the company is likely to sustain in near to medium term on account of steady accruals and low gearing.


Weaknesses

­Moderately Intensive Working Capital Operations
ACTPL's working capital operations remain moderately intensive in nature, as reflected by Gross Current Assets (GCA) days of 149 days in FY2026 (Prov.) compared to 96 days in FY2025. The increase was largely on account of a rise in debtor days to 118 days in FY2026 (Prov.) from 62 days in FY2025. The stretch in receivables was primarily attributable to higher sales recorded towards the end of March 2026, resulting in elevated year-end debtors. Inventory days improved to 28 days in FY2026 (Prov.) from 32 days in FY2025, reflecting better inventory management. Creditor days increased to 94 days in FY2026 (Prov.) from 55 days in FY2025, reflecting higher credit support from suppliers amid lower procurement levels during the year. The elongated payable cycle partially offset the impact of stretched receivables and supported the company's working capital requirements. Further, the average bank utilization stood at moderate at 49.72 per cent in last six months ended September 2026. Acuite believes that the company's ability to efficiently manage receivables and maintain working capital discipline will remain a key monitorable going forward.

Susceptibility of profitability to volatility in input prices, forex fluctuations in a competitive industry
ACTPL operates in a highly fragmented and competitive chemical trading industry, which limits pricing flexibility and exerts pressure on margins. The company's profitability remains susceptible to fluctuations in chemical prices and foreign exchange rates due to its dependence on imported products, although import purchases moderated to around 25% of total procurement in FY2026 from 41% in FY2025. The company also derives a portion of its revenues from exports, which exposes it to currency fluctuations; however, the forex risk is mitigated to an extent through natural hedging arising from imports and exports as well as the use of forward contracts for hedging foreign currency exposures. Nevertheless, earnings remain vulnerable to adverse movements in commodity prices, exchange rates and competitive pressures.

Rating Sensitivities

Potential triggers (individual or collective) for an upward rating action:
  • Improvement in revenues surpassing Rs. 800.00 Cr. while maintaining profitability margins
  • Improvement in the financial risk profile
  • Improvement in working capital operations
Potential triggers (individual or collective) for a downward rating action:
 
  • Significant decline in revenues and profitability
  • Deterioration in financial risk profile with debt to EBITDA above 5 times consistently
  • Elongation in the working capital cycle
Liquidity Position
Adequate

The liquidity position of the company remains adequate with net cash accruals (NCAs) of Rs. 3.62 Cr. in FY2026 (Prov.) against repayment obligation Rs. 0.53 Cr. in the same period. Going forward the company is expected to generate net cash accruals around Rs. 4.00-5.00 Cr. against nil debt repayment obligation. The company had a cash balance of Rs. 0.31 crore as on March 31, 2026 (Prov.). The current ratio stood at 1.52 times as on March 31, 2026 (Prov.). The average fund based working capital utilization of the company is 49.72 per cent for 6 months ended as on September 2026. Acuite believes that the liquidity of the company is likely to remain adequate over the medium term on account of adequate cash accrual over the medium term against no repayment obligations.

 
Outlook

­Stable

 
Other Factors affecting Rating

­None

 

Particulars Unit FY 26 (Provisional) FY 25 (Actual)
Operating Income Rs. Cr. 437.19 505.42
PAT Rs. Cr. 2.04 1.38
PAT Margin (%) 0.47 0.27
Total Debt/Tangible Net Worth Times 0.57 0.27
PBDIT/Interest Times 2.42 1.84
Status of non-cooperation with previous CRA (if applicable)

­Not Applicable

 
Any other information

­None

 
Applicable Criteria
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm
• Trading Entities: https://www.acuite.in/view-rating-criteria-61.htm
Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
15 Jul 2025 Bank Guarantee (BLR) Short Term 3.00 ACUITE A3 (Assigned)
Letter of Credit Short Term 20.00 ACUITE A3 (Assigned)
Letter of Credit Short Term 18.00 ACUITE A3 (Assigned)
Letter of Credit Short Term 16.50 ACUITE A3 (Assigned)
Credit Exposure Limit (FCNR) Short Term 2.50 ACUITE A3 (Assigned)
Cash Credit Long Term 12.00 ACUITE BBB- | Stable (Assigned)
Cash Credit Long Term 7.00 ACUITE BBB- | Stable (Assigned)
Cash Credit Long Term 13.50 ACUITE BBB- | Stable (Assigned)
­

Lender’s Name ISIN Facilities Listing Status Regulated By Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
ICICI BANK LIMITED Not avl. / Not appl. Bank Guarantee (BLR) Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 3.00 Simple ACUITE A3 | Reaffirmed
HSBC Limited Not avl. / Not appl. Cash Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 12.00 Simple ACUITE BBB- | Stable | Reaffirmed
INDUSIND BANK LIMITED Not avl. / Not appl. Cash Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 13.50 Simple ACUITE BBB- | Stable | Reaffirmed
ICICI BANK LIMITED Not avl. / Not appl. Cash Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 7.00 Simple ACUITE BBB- | Stable | Reaffirmed
INDUSIND BANK LIMITED Not avl. / Not appl. Credit Exposure Limit (FCNR) Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 2.50 Simple ACUITE A3 | Reaffirmed
INDUSIND BANK LIMITED Not avl. / Not appl. Letter of Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 16.50 Simple ACUITE A3 | Reaffirmed
HSBC Limited Not avl. / Not appl. Letter of Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 18.00 Simple ACUITE A3 | Reaffirmed
ICICI BANK LIMITED Not avl. / Not appl. Letter of Credit Unlisted RBI Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 20.00 Simple ACUITE A3 | Reaffirmed
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
­

Contacts

List of instruments and names of regulators of the instruments

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in
Acuite Ratings and Research logo